OCALIVA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Oct 2022)
What this means for you
Registered since 02 Aug 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86710865
- Registration number
- 5014396
- Mark type
- Stylized text
- Filed
- 31 Jul 2015
- Published for opposition
- 05 Apr 2016
- Registered
- 02 Aug 2016
- Attorney of record
- Jennifer Sheehan Anderson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of chronic liver diseases
Owner
- INTERCEPT PHARMACEUTICALS, INC., Morristown, NJ, US
- INTERCEPT PHARMACEUTICALS, INC., NEW YORK, NY, US
- RXF Technologies, Inc., Royal Oak, MI, US
- RXF Technologies, Inc., Royal Oak, MI, US
Prosecution history
- 02 Aug 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Oct 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Oct 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Oct 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Apr 2022 — TEAS SECTION 8 & 15 RECEIVED
- 02 Aug 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Sept 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2016 — REGISTERED-PRINCIPAL REGISTER
- 01 Jul 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Jun 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Jun 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 31 May 2016 — USE AMENDMENT FILED
- 23 Jun 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Jun 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 31 May 2016 — TEAS STATEMENT OF USE RECEIVED